These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37538109)

  • 1. Survival prediction of hepatocellular carcinoma by measuring the extracellular volume fraction with single-phase contrast-enhanced dual-energy CT imaging.
    Chen Y; Shi K; Li Z; Wang H; Liu N; Zhan P; Liu X; Shang B; Hou P; Gao J; Lyu P
    Front Oncol; 2023; 13():1199426. PubMed ID: 37538109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage IV pancreatic ductal adenocarcinoma.
    Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nakajo M; Maemura K; Arima S; Yoshiura T
    Eur Radiol; 2020 Mar; 30(3):1679-1689. PubMed ID: 31728691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of liver extracellular volume using dual-energy CT: utility for prediction of liver-related events in cirrhosis.
    Bak S; Kim JE; Bae K; Cho JM; Choi HC; Park MJ; Choi HY; Shin HS; Lee SM; Kim HO
    Eur Radiol; 2020 Oct; 30(10):5317-5326. PubMed ID: 32335746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular volume fraction using contrast-enhanced CT is useful in differentiating intrahepatic cholangiocellular carcinoma from hepatocellular carcinoma.
    Honda T; Onishi H; Fukui H; Yano K; Kiso K; Nakamoto A; Tsuboyama T; Ota T; Tatsumi M; Tahara S; Kobayashi S; Eguchi H; Tomiyama N
    Front Oncol; 2023; 13():1214977. PubMed ID: 37483497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of dual-energy computed tomography for oral cancer image.
    Tanaka O; Matsubara M; Ehara Y; Taniguchi T; Muramatsu Y; Hasegawa Y; Makita C; Matsuo M; Sumitomo S
    Oral Radiol; 2021 Oct; 37(4):585-590. PubMed ID: 33386526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-layer DECT for multiphasic hepatic CT with 50 percent iodine load: a matched-pair comparison with a 120 kVp protocol.
    Nagayama Y; Nakaura T; Oda S; Utsunomiya D; Funama Y; Iyama Y; Taguchi N; Namimoto T; Yuki H; Kidoh M; Hirata K; Nakagawa M; Yamashita Y
    Eur Radiol; 2018 Apr; 28(4):1719-1730. PubMed ID: 29063254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
    Lee JW; Yun M; Cho A; Han KH; Kim DY; Lee SM; Lee JD
    Ann Nucl Med; 2015 Jun; 29(5):400-8. PubMed ID: 25652647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of ¹⁸F-FDG Uptake in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization or Concurrent Chemoradiotherapy: A Multicenter Retrospective Cohort Study.
    Lee JW; Oh JK; Chung YA; Na SJ; Hyun SH; Hong IK; Eo JS; Song BI; Kim TS; Kim DY; Kim SU; Moon DH; Lee JD; Yun M
    J Nucl Med; 2016 Apr; 57(4):509-16. PubMed ID: 26742711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of liver extracellular volume using dual-energy CT for ruling out high-risk varices in cirrhosis.
    Hong S; Kim JE; Cho JM; Choi HC; Won JH; Na JB; Choi DS; Park MJ; Choi HY; Shin HS; Cho HC; Kim HO
    Eur J Radiol; 2022 Mar; 148():110151. PubMed ID: 35032849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The course and prognostic value of tumor stiffness detected by ultrasound elastography for transarterial chemoembolization of hepatocellular carcinoma.
    Hou S; Hua S; Cui K; Liu F; Ding K; Yuan J
    Quant Imaging Med Surg; 2023 Jun; 13(6):3962-3972. PubMed ID: 37284088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-Eluting Bead Transarterial Chemoembolization Versus Radiofrequency Ablation as an Initial Treatment of Single Small (≤ 3 cm) Hepatocellular Carcinoma.
    Lee S; Jeong YY; Lee BC; Shin SS; Heo SH; Kim HO; Park C; Jeong WG
    J Korean Med Sci; 2023 Oct; 38(42):e362. PubMed ID: 37904659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging Predictors of Survival in Patients with Single Small Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
    Park C; Kim JH; Kim PH; Kim SY; Gwon DI; Chu HH; Park M; Hur J; Kim JY; Kim DJ
    Korean J Radiol; 2021 Feb; 22(2):213-224. PubMed ID: 32901464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic and pancreatic extracellular volume fraction analysis using contrast-enhanced CT in patients with diabetes mellitus and pre-diabetes.
    Fukui H; Onishi H; Nakamoto A; Tsuboyama T; Ota T; Honda T; Kiso K; Yoshidome E; Enchi Y; Tatsumi M; Tomiyama N
    Jpn J Radiol; 2024 Jun; 42(6):599-611. PubMed ID: 38351253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of noise-optimized virtual monoenergetic dual-energy computed tomography on image quality in patients with renal cell carcinoma.
    Martin SS; Wichmann JL; Pfeifer S; Leithner D; Lenga L; Reynolds MA; D'Angelo T; Hammerstingl R; Gruber-Rouh T; Vogl TJ; Albrecht MH
    Eur J Radiol; 2017 Dec; 97():1-7. PubMed ID: 29153358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Ni JY; Fang ZT; Sun HL; An C; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH
    Eur Radiol; 2020 Apr; 30(4):2377-2390. PubMed ID: 31900694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of dual-energy CT in nonspecific terminal ileitis.
    Xu X; Zhu J; Wang X; Zhu C; Wu X
    Jpn J Radiol; 2022 Oct; 40(10):1069-1078. PubMed ID: 35576041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal Ablation Versus Stereotactic Body Radiotherapy After Transarterial Chemoembolization for Inoperable Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis.
    Nabavizadeh N; Jahangiri Y; Rahmani R; Tomozawa Y; Geeratikun Y; Chen Y; Hung A; Degnin C; Farsad K
    AJR Am J Roentgenol; 2021 Sep; 217(3):691-698. PubMed ID: 32997517
    [No Abstract]   [Full Text] [Related]  

  • 18. CT texture analysis in predicting treatment response and survival in patients with hepatocellular carcinoma treated with transarterial chemoembolization using random forest models.
    An H; Bhatia I; Cao F; Huang Z; Xie C
    BMC Cancer; 2023 Mar; 23(1):201. PubMed ID: 36869284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
    Peng Z; Chen S; Xiao H; Wang Y; Li J; Mei J; Chen Z; Zhou Q; Feng S; Chen M; Qian G; Peng S; Kuang M
    Radiology; 2019 Jul; 292(1):237-247. PubMed ID: 31135299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of optimal virtual monochromatic energy level for target delineation of brain metastases in radiosurgery using dual-energy CT.
    Karino T; Ohira S; Kanayama N; Wada K; Ikawa T; Nitta Y; Washio H; Miyazaki M; Teshima T
    Br J Radiol; 2020 Feb; 93(1106):20180850. PubMed ID: 31825643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.